Life Sciences
REGENXBIO
A modern, human-centric digital ecosystem that inspires user engagement

Business Situation: REGENXBIO sought out the experts at Boston Digital to achieve the primary objectives for their new website: establish a modernized online presence reflective of their innovative spirit, emphasize their competitive edge, and foster a patient-centric atmosphere that inspires engagement.
Our Solution: Our skilled teams joined forces to create a cutting-edge, human-centered digital ecosystem for REGENXBIO that boasts captivating visual design and engaging user experience. We revamped their website into an adaptable, scalable hub that effectively showcases their forward-thinking and highlights the game-changing innovations they bring to the industry.
Since its founding in 2009 by Ken Mills and FOXKISER, REGENXBIO has been a leader in the gene therapy field, driven by an ongoing commitment to develop gene therapies that improve treatment options for people with significant unmet needs. Today, REGENXBIO has end-to-end capabilities in the development of AAV Therapeutics and is advancing the internal pipeline to treat common and rare diseases.
We partnered with REGENXBIO to execute a top-down website redesign that transformed the site into a seamless digital experience fit for the live-saving brand.
We’re digital trailblazers, making headlines with our latest research, projects and thought leadership.